Recent Press Releases

Boehringer Ingelheim and Lilly Diabetes Alliance to Present Data from 35 Studies at the American Diabetes Association's 75th Scientific Sessions®

Clinical and pre-clinical data on compounds representing several of the largest diabetes treatment classes will be presented

RIDGEFIELD,

U.S. Food and Drug Administration Approves Humalog® 200 units/mL KwikPen®

Marks approval of first concentrated mealtime insulin analog in the U.S.

Halozyme, Ventana Enter Into Global Agreement To Collaboratively Develop Companion Diagnostic For Cancer Treatment

SAN DIEGO, May 27, 2015 /PRNewswire/ -- Halozyme Therapeutics, Inc.

Amgen To Advance Understanding Of The Treatment Of Blood Cancers At 20th Congress of European Hematology Association (EHA)

THOUSAND OAKS, Calif., May 27, 2015 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will present

Lilly to Present New Clinical Data at 75th American Diabetes Association® Scientific Sessions

Range of abstracts reflects Lilly Diabetes' comprehensive portfolio

INDIANAPOLIS, May 27, 2015 /PRNe

Amgen To Present At The Jefferies 2015 Global Healthcare Conference

THOUSAND OAKS, Calif., May 27, 2015 /PRNewswire/ -- Amgen (NASDAQ: AMGN) will present at the Jefferies 2

Bayer has outstanding perspectives as a pure Life Science company

Very successful fiscal 2014 both strategically and operationally / Dividend increase to EUR 2.25 per share for 2014 proposed / Employees share in the company's success through total bonuses of...

Novartis presents new data on 21 medicines and 11 investigational compounds at ASCO and EHA

EAST HANOVER, N.J., May 27, 2015 -- Novartis will highlight the strength of its expanded oncology portfolio in 21 medicines and 11 investigational compounds across more than 185 data presentations at...

Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR

DUBLIN, May 22, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that a panel of the U.S. Court of Appeals for the Second Circuit has issued a ruling upholding a December 15, 2014...

Amgen to terminate participation in co-development and commercialization of brodalumab

THOUSAND OAKS, Calif., May 22, 2015 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the Company has

Amgen Receives Positive CHMP Opinion For Use Of Repatha™ (Evolocumab) For The Treatment Of High Cholesterol

First Positive Regulatory Agency Determination for a PCSK9 Inhibitor

THOUSAND OAKS, Calif., May 22, 2015

New treatment option recommended for patients with advanced melanoma

Keytruda extends range of treatment options for melanoma patients with poor prognosis The European Medicines Agency (EMA) has recommended granting a marketing authorisation for Keytruda...

New treatment option for patients with advanced lung cancer

Recommendation of Nivolumab BMS follows previous positive opinion for nivolumab to treat advanced melanoma The European Medicines Agency (EMA) has recommended granting a marketing...

PuriCore Release: Announces The Appointment Of Alex Martin As CEO Life Sciences Executive To Drive Future Strategy

19 May 2015 – PuriCore plc (AIM: PURI), an international company focused on safe and effective protection against the spread of infectious pathogens, today announces that Alex Martin will be...

Amgen Receives Positive CHMP Opinion For Use Of Repatha™ (Evolocumab) For The Treatment Of High Cholesterol

First Positive Regulatory Agency Determination for a PCSK9 Inhibitor  THOUSAND OAKS, Calif., May 22, 2015 /PRNewswire/ -- Amgen (AMGN) today announced that the Committee for Medicinal Products...

CVS Health and Omnicare Sign Definitive Agreement for CVS Health to Acquire Omnicare

WOONSOCKET, R.I.and CINCINNATI, May 21, 2015 /PRNewswire/ -- CVS Health Corporation (NYSE:CVS) and Omnicare, Inc. (NYSE:OCR) announced today that they have entered into a definitive agreement for CVS...

Divestment of portfolio of branded and generic products to Strides entities

Divestment of portfolio of branded and generic products to Strides entities 21/05/15: Shauneen Beukes Aspen is pleased to announce that certain of its wholly owned Australian subsidiaries...